Evidence map›Paper›PMID 21764830›Full record

ArticleJapanese journal of clinical oncology2011

Burden on oncologists when communicating the discontinuation of anticancer treatment.

Hiroyuki Otani, Tatsuya Morita, Taito Esaki, Hiroshi Ariyama, Koichiro Tsukasa, Akira Oshima, Keiko Shiraisi

Abstract read
In one paragraph

Article in Japanese journal of clinical oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. A Joanna Briggs Institute Framework Approach to Shared Decision Making in End-of-Life.Health expectations : an international journal of public participation in health care and health policy · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. "Maintaining hope:" challenges in counseling latino patients with advanced cancer.Journal of psychosocial oncology research and practice · 2020
    Article
  10. Article
  11. Article
  12. What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  13. Japanese physicians' attitudes toward end-of-life discussion with pediatric patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroyuki OtaniDepartment of Palliative Care Team, and Psycho-Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1347, Japan. cas60020@pop21.odn.ne.jp
Tatsuya Morita
Taito Esaki
Hiroshi Ariyama
Koichiro Tsukasa
Akira Oshima
Keiko Shiraisi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCommunicating the discontinuation of anticancer treatment to patients is a difficult task. The primary aim of this study was to clarify the level of oncologist-reported burden when communicating about discontinuation of an anticancer treatment. The secondary aims were (i) to identify the sources of burden contributing to their levels and (ii) to explore the useful strategies to alleviate their burden.

methodsA multicenter nationwide questionnaire survey was conducted on 620 oncologists across Japan (response rate, 67%).

resultsHigh levels of perceived burden were reported by 47% of respondents, and 17% reported that they sometimes, often or always wanted to stop oncology work because of this burden. There was a significant association between high levels of burden and: a feeling that breaking bad news would deprive the patient of hope; concern that the patient's family would blame the oncologist; concern that the patient may lose self-control; and a feeling that there was not enough time to break the bad news. Strategies perceived to be useful by oncologists included training in how to effectively communicate to patients discontinuation of anticancer treatment, a reduction in total workload to allow sufficient time to break bad news, and development of a multidisciplinary model to facilitate cooperation with other professionals and facilities.

conclusionsMany oncologists reported high levels of burden relating to communication of discontinuation of anticancer treatment. A specific communication skills training program, sufficient time for communication and development of a multidisciplinary model could help alleviate the burden on oncologists.

Indexed as

Medical OncologyStress, PsychologicalTruth DisclosureWithholding TreatmentAdultCross-Sectional StudiesEmotionsFemaleHumansJapanLogistic ModelsMaleMiddle AgedNeoplasmsPhysician-Patient RelationsPhysicians

Identifiers

PMID21764830
PMCPMC3146312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.